Publication | Closed Access

Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells

NanomedicineNanotherapeuticsHealth SciencesPolymer-drug ConjugateMedicineCyclodextrin ProductionMultidrug ResistanceNano-drug DeliveryTumor TargetingPharmacologyRadiation OncologyPh-responsive Cyclodextrin-derived NanomedicineDrug Resistance